Unicoat Pharma ApS: Financial statements 2019
CVR: 37166707
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Unicoat Pharma ApS (CVR 37166707) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 648,322 and a net result of DKK 522,695 compared with DKK 362,088 the year before. That is an increase of 44.3% compared with the year before. Equity in the 2019 report amounted to DKK 712,484. The solvency ratio was 22.2%.
- Gross Profit
- DKK 648,322
- Profit/Loss
- DKK 522,695
- Equity
- DKK 712,484
- Total Assets
- DKK 3,209,906
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 648 t. | 523 t. | 712 t. | - |
| 2018 | - | 449 t. | 362 t. | 490 t. | - |
| 2017 | - | 431 t. | 344 t. | 428 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Unicoat Pharma ApS has published its annual report for 2018. Gross profit came to DKK 449,242, and the net result was DKK 362,088.
About Unicoat Pharma ApS
Unicoat Pharma ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Overfladebehandling af metal. The management consists of Morten Clausen, Amanda Ryberg and Magnus Knorr Clausen. The company is owned by M C Holding ApS, MCVA Holding ApS and A Ryberg Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. Equity in the 2025 report amounted to DKK 507,241.